{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:10:58Z","timestamp":1789603858786,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,18]],"date-time":"2021-05-18T00:00:00Z","timestamp":1621296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007642","name":"University of Rome Tor Vergata","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007642","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ymeth.2021.05.011","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T11:59:11Z","timestamp":1620993551000},"page":"74-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment"],"prefix":"10.1016","volume":"201","author":[{"given":"Lorenzo","family":"Piermatteo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Scutari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Chirichiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Alkhatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Malagnino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerio","family":"Iapadre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Sarmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Andreoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ceccherini-Silberstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Salpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Svicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymeth.2021.05.011_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2019.06.004","article-title":"Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success","author":"Alteri","year":"2019","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ymeth.2021.05.011_b0010","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiz411","article-title":"Establishment of a Seronegative Occult Infection With an Active Hepatitis B Virus Reservoir Enriched of Vaccine Escape Mutations in a Vaccinated Infant After Liver Transplantation","volume":"220","author":"Salpini","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymeth.2021.05.011_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/life10110302","article-title":"Long-term sars-cov-2 infection associated with viral dissemination in different body fluids including bile in two patients with acute cholecystitis","author":"Scutari","year":"2020","journal-title":"Life."},{"key":"10.1016\/j.ymeth.2021.05.011_b0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12977-018-0399-0","article-title":"Digital PCR as a tool to measure HIV persistence","author":"Rutsaert","year":"2018","journal-title":"Retrovirology."},{"key":"10.1016\/j.ymeth.2021.05.011_b0025","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1080\/22221751.2020.1772678","article-title":"ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens","volume":"9","author":"Suo","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ymeth.2021.05.011_b0030","doi-asserted-by":"crossref","unstructured":"S.L. Schwartz, A.C. Lowen, Droplet digital PCR: a novel method for detection of influenza virus defective interfering particles, (n.d.). https:\/\/doi.org\/10.1016\/j.jviromet.2016.08.023.","DOI":"10.1016\/j.jviromet.2016.08.023"},{"key":"10.1016\/j.ymeth.2021.05.011_b0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virol.2017.08.005","article-title":"Droplet digital PCR for rapid enumeration of viral genomes and particles from cells and animals infected with orthopoxviruses","volume":"511","author":"Americo","year":"2017","journal-title":"Virology."},{"key":"10.1016\/j.ymeth.2021.05.011_b0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.coviro.2016.06.003","article-title":"HBV cure: why, how, when?","volume":"18","author":"Levrero","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymeth.2021.05.011_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Taormina Workshop on Occult HBV Infection Faculty Members, Update of the statements on biology and clinical impact of occult hepatitis b virus infection","author":"Raimondo","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymeth.2021.05.011_b0050","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1007\/s00216-016-9861-9","article-title":"Evaluation of the performance of quantitative detection of the Listeria monocytogenes prfA locus with droplet digital PCR","volume":"408","author":"Witte","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ymeth.2021.05.011_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-49043-x","article-title":"Optimisation of robust singleplex and multiplex droplet digital PCR assays for high confidence mutation detection in circulating tumour DNA","volume":"9","author":"Rowlands","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymeth.2021.05.011_b0060","doi-asserted-by":"crossref","unstructured":"S.K. Ladner, M.J. Otto, C.S. Barker, \u2020 Katie Zaifert, G.-H. Wang, J.-T. Guo, C. Seeger, R.W. King, Inducible Expression of Human Hepatitis B Virus (HBV) in Stably Transfected Hepatoblastoma Cells: a Novel System for Screening Potential Inhibitors of HBV Replication, 1997.","DOI":"10.1128\/AAC.41.8.1715"},{"issue":"Suppl 1","key":"10.1016\/j.ymeth.2021.05.011_b0065","article-title":"Limit of blank, limit of detection and limit of quantitation","volume":"29","author":"Armbruster","year":"2021","journal-title":"Clin. Biochem. Rev."},{"key":"10.1016\/j.ymeth.2021.05.011_b0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jviromet.2014.02.020","article-title":"Low copy target detection by Droplet Digital PCR through application of a novel open access bioinformatic pipeline, \u201cdefinetherain\u201d","volume":"202","author":"Jones","year":"2014","journal-title":"J. Virol. Methods."},{"key":"10.1016\/j.ymeth.2021.05.011_b0075","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1007\/s00216-015-8773-4","article-title":"Ddpcrquant: Threshold determination for single channel droplet digital PCR experiments","volume":"407","author":"Trypsteen","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ymeth.2021.05.011_b0080","doi-asserted-by":"crossref","unstructured":"D. Burdette, S. Lazerwith, G. Sciences, J. Yang, H. Chan, W. Delaney, I. V Assembly, B.B. Feierbach, Evidence of an Infectious Virus Reservoir in Suppressed Chronic Hepatitis B Patients, (n.d.). https:\/\/doi.org\/10.21203\/rs.3.rs-100058\/v1.","DOI":"10.21203\/rs.3.rs-100058\/v1"},{"key":"10.1016\/j.ymeth.2021.05.011_b0085","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/MCG.0000000000000170","article-title":"Residual amount of HBV DNA in serum is related to relapse in chronic hepatitis B patients after cessation of nucleos(t)ide analogs","volume":"49","author":"Jiang","year":"2015","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.ymeth.2021.05.011_b0090","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2014-307596","article-title":"Oral antiviral therapy for HBeAg negative chronic hepatitis B: Better stop or continue?","author":"Lampertico","year":"2015","journal-title":"Gut."},{"key":"10.1016\/j.ymeth.2021.05.011_b0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11010-006-9167-x","article-title":"Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells","volume":"290","author":"Severi","year":"2006","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ymeth.2021.05.011_b0100","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.13091","article-title":"Can we stop nucleoside analogues before HBsAg loss?","author":"Papatheodoridi","year":"2019","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.ymeth.2021.05.011_b0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/liv.13314","article-title":"When can we stop nucleoside analogues in patients with chronic hepatitis B?","volume":"37","author":"Chong","year":"2017","journal-title":"Liver Int."},{"key":"10.1016\/j.ymeth.2021.05.011_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104992","article-title":"Perspectives on stopping nucleos(t)ide analogues therapy in patients with chronic hepatitis B","volume":"185","author":"Tout","year":"2021","journal-title":"Antiviral Res."},{"key":"10.1016\/j.ymeth.2021.05.011_b0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/liv.13654","article-title":"Stopping long-term treatment with nucleos(t)ide analogues is a favourable option for selected patients with HBeAg-negative chronic hepatitis B","volume":"38","author":"van B\u00f6mmel","year":"2018","journal-title":"Liver Int."},{"key":"10.1016\/j.ymeth.2021.05.011_b0120","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2017.07.012","article-title":"Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients \u2013 FINITE study","volume":"67","author":"Berg","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymeth.2021.05.011_b0125","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-0037-1606212","article-title":"Challenges to a Cure for HBV Infection","volume":"37","author":"Testoni","year":"2017","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ymeth.2021.05.011_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrgastro.2016.7","article-title":"Global strategies are required to cure and eliminate HBV infection","volume":"13","author":"Revill","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymeth.2021.05.011_b0135","first-page":"1","article-title":"Hepatitis B virus cure: Targets and future therapies","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymeth.2021.05.011_b0140","doi-asserted-by":"crossref","DOI":"10.1002\/hep.22945","article-title":"Reactivation of hepatitis B","volume":"49","author":"Hoofnagle","year":"2009","journal-title":"Hepatology."},{"key":"10.1016\/j.ymeth.2021.05.011_b0145","doi-asserted-by":"crossref","DOI":"10.1111\/jvh.13101","article-title":"A snapshot of virological presentation and outcome of immunosuppression-driven HBV reactivation from real clinical practice: Evidence of a relevant risk of death and evolution from silent to chronic infection","volume":"26","author":"Salpini","year":"2019","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.ymeth.2021.05.011_b0150","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2018-04-848044","article-title":"Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy","author":"Kusumoto","year":"2019","journal-title":"Blood."}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202321001377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202321001377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:41:31Z","timestamp":1760924491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202321001377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":30,"alternative-id":["S1046202321001377"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2021.05.011","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Droplet digital PCR assay as an innovative and promising highly sensitive assay to unveil residual and cryptic HBV replication in peripheral compartment","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2021.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}